JG
DXCM icon

Jefferies Group’s DexCom DXCM Stock Holding History

Jefferies Group’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$766K Buy
+9,516
New +$806K 0.01% 882
2022
Q2 		– Sell
-72,128
Closed -$9.23M – 1610
2022
Q1 		$9.23M Sell
72,128
-50,072
-41% -$5.48M 0.06% 252
2021
Q4 		$16.4M Sell
122,200
-86,584
-41% -$12.4M 0.1% 177
2021
Q3 		$28.5M Buy
208,784
+165,984
+388% +$20.9M 0.21% 76
2021
Q2 		$4.57M Buy
42,800
+2,800
+7% +$269K 0.03% 495
2021
Q1 		$3.59M Sell
40,000
-10,000
-20% -$939K 0.03% 486
2020
Q4 		$4.62M Buy
50,000
+36,680
+275% +$3.28M 0.04% 436
2020
Q3 		$1.37M Buy
+13,320
New +$1.39M 0.02% 705
2020
Q1 		– Sell
-63,032
Closed -$3.45M – 2182
2019
Q4 		$3.45M Sell
63,032
-7,672
-11% -$364K 0.03% 728
2019
Q3 		$2.64M Buy
70,704
+61,000
+629% +$2.37M 0.02% 909
2019
Q2 		$364K Buy
+9,704
New +$305K ﹤0.01% 1826
2019
Q1 		– Sell
-18,464
Closed -$553K – 2384
2018
Q4 		$553K Sell
18,464
-177,440
-91% -$5.63M ﹤0.01% 1423
2018
Q3 		$7.01M Buy
195,904
+87,312
+80% +$2.71M 0.05% 404
2018
Q2 		$2.58M Buy
+108,592
New +$2.3M 0.01% 772
2018
Q1 		– Sell
-72,064
Closed -$1.03M – 2329
2017
Q4 		$1.03M Buy
+72,064
New +$937K ﹤0.01% 1340
2017
Q3 		– Sell
-62,264
Closed -$1.14M – 2395
2017
Q2 		$1.14M Buy
62,264
+50,160
+414% +$926K 0.01% 1226
2017
Q1 		$256K Sell
12,104
-11,776
-49% -$230K ﹤0.01% 1905
2016
Q4 		$356K Buy
23,880
+19,028
+392% +$337K ﹤0.01% 1707
2016
Q3 		$106K Buy
+4,852
New +$108K ﹤0.01% 2030
2015
Q3 		– Sell
-258,464
Closed -$5.17M – 2457
2015
Q2 		$5.17M Buy
+258,464
New +$4.54M 0.03% 499
2014
Q1 		– Sell
-28,864
Closed -$256K – 2100
2013
Q4 		$256K Buy
+28,864
New +$228K ﹤0.01% 1462

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jefferies Group's DXCM Position: Q3 2022 in Review

Jefferies Group opened a new position in DexCom (DXCM) in Q3 2022: 9,516 shares worth $766K. The stake represents 0.01% of the portfolio and ranks #882 among its holdings. This is a return to the name: Jefferies Group previously reported a position in DXCM as recently as Q1 2022.

Jefferies Group first reported a position in DXCM in Q4 2013 and has held it in 21 quarters since. The position peaked at $28.5M in Q3 2021. 794 funds tracked by Wall St. Rank hold DXCM as of Q3 2022.

  • Jefferies Group held 9,516 shares of DexCom worth $766K as of Q3 2022.
  • DexCom was a new Jefferies Group position in Q3 2022.
  • DexCom made up 0.01% of Jefferies Group's portfolio in Q3 2022, its #882 holding.
  • Jefferies Group first reported a position in DexCom in Q4 2013 and has held it in 21 quarters since.
  • Jefferies Group's DexCom position peaked at $28.5M in Q3 2021.
  • 794 funds tracked by Wall St. Rank held DexCom as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.